Ad
related to: review, raymond v raymond
Search results
Investing in Archer Aviation Inc
Knox Daily· 4 days agoAs a result of the transaction, Stellantis N.V. now holds 37,851,720 shares, worth roughly $152.16 million. Canaccord...price target was $9. A number of analysts have revised ...
Q1 2024 G1 Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoRaj will provide the status of our ongoing TNBC trials and remind you of the timing of the data from each. John will then provide the financial results for the quarter, including our revenue ...
Arkansas Court of Appeals | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 1 day agoThe Arkansas Court of Appeals released opinions Wednesday. The court's ruling and the names of the...
Court directs Texas judge to decide CFPB credit card fee case by May 10
Reuters· 2 days agoA federal appeals court has directed a judge in Texas to decide by the end of next week whether to...
Louis Vuitton gets approval for Worth Ave. storefront design from Palm Beach board
Gannett via AOL· 3 days agoLouis...Vuitton store shows that the first floor will feature displays, try-on rooms and seating...
Q1 2024 FTAI Aviation Ltd Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoAerospace products had yet another excellent quarter with 70.3 million of EBITDA at an overall EBITDA margin of 37%. We sold 72 CFM56 modules in Q1 to 16 unique customers. Additionally, we sold ...
SpaceX asks Texas judge to block NLRB case over severance agreements
Reuters· 7 days agoSpaceX has asked a Texas federal judge to block the National Labor Relations Board from pursuing...
Exclusive: Inside the Rise of Jesse Lyu and the Rabbit R1
Inverse· 6 days agoEveryone seems entranced by Jesse Lyu, the new AI prophet. Clad head to toe in black, Lyu stands on...
Dyne Therapeutics, Inc. (NASDAQ:DYN) Given Consensus Recommendation of “Buy” by Analysts
ETF DAILY NEWS· 4 days agoShares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have received a consensus recommendation of “Buy” from the seven research firms that are covering the stock, MarketBeat reports ...
